Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2005
09/01/2005US20050192284 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
09/01/2005US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders
09/01/2005US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections
09/01/2005US20050191724 Nematode-extracted serine protease inhibitors and anticoagulant proteins
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005CA2557539A1 Indanol derivative
08/2005
08/31/2005EP1568709A2 Purification of fibrinogen
08/31/2005EP1568691A1 Erythropoietin production accelerator
08/31/2005EP1567182A2 Preventing desensitization of receptors
08/31/2005EP1567160A2 Method of treatment of myocardial infarction
08/31/2005EP1567112A2 Novel chemical compounds
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1073634B1 Method for producing enantiomerically pure n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/31/2005CN1662548A Regeneration of endogenous myocardial tissue by induction of neovascularization
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662504A 2, 5-disubstituted 3-mercaptopentanoic acid
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662241A Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
08/31/2005CN1662234A Use of thio-oxindole derivatives in treatment of hormone-related conditions
08/31/2005CN1662226A Monocompartment osmotic controlled drug delivery system
08/31/2005CN1661109A Novel targets for obesity from skeletal muscle
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660443A Application of ramification of methoxypolythylene glycol, chemical modified general type red blood cell and preparation method
08/31/2005CN1660420A Compound combination of Chinese traditional medicine in use for lowering viscosity of whole blood, thrombolysis and reducing blood fat
08/31/2005CN1660409A Technique for preparing injection of protein polyeptide
08/31/2005CN1660390A Medication and health food in use for lowering blood sugar, improving function of intestinal tract and reducing platelet aggergation
08/31/2005CN1660351A Combination of medication of containing astragalus root and dragon's blood resin and application
08/31/2005CN1660347A Yinhuang combination, oral taking preparation and injection preparation, preparing method and application
08/31/2005CN1660321A Medicinal preparation of extractive from compound aspirin and rice fermentred with red yeast
08/31/2005CN1660314A 'Mailuoning' injection and preparation method
08/31/2005CN1660290A Hematogenesis capsule and preparation method
08/31/2005CN1660258A 'Longxuejie' soft capsule and preparation method
08/31/2005CN1660254A Anthemonhagic medicament for quick blood coagulation and diminish inflammation
08/31/2005CN1660246A Compound preparation of Chinese traditional medicine regulating menstruation and nourishing the blood
08/31/2005CN1660190A 'Qili' capsule for treating wound and preparation method
08/31/2005CN1660163A Method for extracting general iridoid glycoside from 'Duyiwei' of Tibet medicine and application
08/31/2005CN1660101A Compound medicinal preparation of ligustrazine of phosphoric acids and xylitol, and preparation method
08/31/2005CN1216880C Preparation method of iso propylidene shikimic acid and its new use
08/31/2005CN1216872C Quinazoline derivatives and pharmaceutical applications thereof
08/31/2005CN1216618C A TCM compound recipe notoginseng capsule and method for preparing the same
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936633 Pyrrolidinone derivatives
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936610 Heterocyclic derivatives
08/30/2005US6936604 Treating hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis and water retention
08/30/2005US6936282 Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA1341490C Dna functional group and plasmid coding for hirudine, transformed yeast, preparation process for hirudine, resulting hirudine, and its pharmaceutical use
08/30/2005CA1341489C Family of primate hematopoietic growth factors
08/25/2005WO2005078072A1 Regulatory cell controlling immunological activity of t cell
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands
08/25/2005US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis
08/25/2005US20050187188 Methods for the treatment of a traumatic central nervous system injury
08/25/2005US20050187185 for tautening skin, in particular for reducing the size of wrinkles in the facial region in a long-lasting manner; comprising crosslinked or uncrosslinked hyaluronic acid associated with heparin
08/25/2005US20050187152 Prevention and treatment of hypergastrinemia
08/25/2005US20050186665 Expressed ligand - vascular intercellular signaling molecule
08/25/2005US20050186664 Albumin fusion proteins
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186649 Inhibitors of human plasmin derived from the kunitz domains
08/25/2005US20050186575 Corona-virus-like particles comprising functionally deleted genomes
08/25/2005US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same
08/25/2005US20050186198 Serine protease inhibitors
08/25/2005DE29924789U1 New, stable crystalline polymorph (form III) of the diuretic torasemide, by controlled acidification of alkaline solutions, has more rapid dissolution than form I
08/25/2005DE19833476B4 Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie Genetically modified CD34-negative adherently growing haematopoietic stem cells and their use in gene therapy
08/25/2005CA2558879A1 Regulatory cell controlling immunological activity of t cell
08/25/2005CA2554378A1 Bicycloamide derivative
08/24/2005EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use
08/24/2005EP1565174A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
08/24/2005EP1360185B1 Carboline derivatives
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
08/24/2005EP1246919B1 Progenitor cell preservation factors and related methods and products
08/24/2005EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
08/24/2005EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
08/24/2005EP1086122B1 Pyrazinone protease inhibitors
08/24/2005EP1074631B1 Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof
08/24/2005CN1659288A Method to inhibit cell growth using oligonucleotides
08/24/2005CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors
08/24/2005CN1659180A Novel recombinant anticoagulant proteins
08/24/2005CN1659162A Tricyclic thrombin receptor antagonists
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659147A Pyridazine derivatives
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament
08/24/2005CN1658869A N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
08/24/2005CN1658863A Severe sepsis preventive therapeutic agent
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/24/2005CN1657537A Central body located gene and its use in medicinal region
08/24/2005CN1657098A Preparation method of earthworm kinase dry powder
08/24/2005CN1657063A Oral liquid for treating paramenia and dys functional uterine bleeding
08/24/2005CN1657053A Anti-coagulation and antiembolus function of EGP
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 671